Initiatiefnota van de leden Ploumen, Van Gerven en Ellemeet: “Big Farma: niet gezond!”

This motion, introduced by members Ploumen, Van Gerven, and Ellemeet, addresses concerns regarding the influence and practices of large pharmaceutical companies. It seeks to examine how the industry affects public health and whether current systems prioritize profit over patient access to affordable medicine. The proposal primarily affects the pharmaceutical industry and government health oversight. It aims to increase transparency in drug pricing and research and development costs.